Original language | English (US) |
---|---|
Pages (from-to) | 555-557 |
Number of pages | 3 |
Journal | JACC: CardioOncology |
Volume | 4 |
Issue number | 4 |
DOIs | |
State | Published - Nov 2022 |
ASJC Scopus subject areas
- Oncology
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: JACC: CardioOncology, Vol. 4, No. 4, 11.2022, p. 555-557.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Racial Differences in Chronic Stress/Allostatic Load Variation Due to Androgen Deprivation Therapy in Prostate Cancer
AU - Stabellini, Nickolas
AU - Cullen, Jennifer
AU - Moore, Justin Xavier
AU - Cao, Lifen
AU - Agarwal, Neeraj
AU - Hamerschlak, Nelson
AU - Waite, Kristin
AU - Montero, Alberto J.
AU - Barnholtz-Sloan, Jill S.
AU - Guha, Avirup
N1 - Funding Information: Mr Stabellini is supported through funding from the Sociedade Beneficente Israelita Brasileira Albert Einstein on the program “Marcos Lottenberg & Marcos Wolosker International Fellowship for Physicians Scientist – Case Western.” Dr Agarwal has served as a consultant for Astellas, AstraZeneca, Aveo, Bayer, Bristol Myers Squibb, Calithera, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Foundation Medicine, Genentech, Gilead, Janssen, Merck, MEI Pharma, Nektar, Novartis, Pfizer, Pharmacyclics, and Seattle Genetics; and has received research funding to the institution from Astellas, AstraZeneca, Bavarian Nordic, Bayer, Bristol Myers Squibb, Calithera, Celldex, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Genentech, Gilead, GlaxoSmithKline, Immunomedics, Janssen, Medivation, Merck, Nektar, New Link Genetics, Novartis, Pfizer, Prometheus, Rexahn, Roche, Sanofi, Seattle Genetics, Takeda, and Tracon. Dr Waite is a full-time, paid contractor of the NCI/NIH. Dr Barnholtz-Sloan is a full-time, paid employee of the NCI/NIH. Dr Guha is supported by American Heart Association-Strategically Focused Research Network Grants in Disparities in Cardio-Oncology (#847740, #863620). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2022/11
Y1 - 2022/11
UR - http://www.scopus.com/inward/record.url?scp=85141972295&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141972295&partnerID=8YFLogxK
U2 - 10.1016/j.jaccao.2022.10.004
DO - 10.1016/j.jaccao.2022.10.004
M3 - Article
AN - SCOPUS:85141972295
SN - 2666-0873
VL - 4
SP - 555
EP - 557
JO - JACC: CardioOncology
JF - JACC: CardioOncology
IS - 4
ER -